Bradycardia during therapy for multiple myeloma with thalidomide-Reference-Cited by-同舟云学术

Bradycardia during therapy for multiple myeloma with thalidomide

Published:2004-04 Issue:8 Volume:93 Page:1052-1055
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Fahdi Ibrahim Elias,Gaddam Venkat,Saucedo Jorge F,Kishan Channarayapatna V,Vyas Keyur,Deneke Matthew G,Razek Hani,Thorn Brett,Bissett Joseph K,Anaisse Elias,Barlogie Bart,Mehta Jawahar L

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference16 articles.

1. Studies on the anti-inflammatory properties of thalidomide;Barnhill;J Am Acad Dermatol,1984

2. Thalidomide exerts its inhibitory action on TNF-α by enhancing the mRNA degradation;Moreira;J Exp Med,1993

3. Thalidomide is an inhibitor of angiogenesis;D'Amato;Proc Natl Acad Sci USA,1994

4. Significant response of oral aphthosis to thalidomide treatment;Grinspan;J Am Acad Dermatol,1985

5. Thalidomide in the treatment of the mucocutaneous lesions of Behçet's syndrome;Hamuryudan;Ann Intern Med,1998

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiac Complications of Multiple Myeloma Treatments;Cardiology in Review;2024-09-10

2. Atrioventricular re-entrant tachycardia and atrioventricular node re-entrant tachycardia in a patient with cancer under chemotherapy: a case report and literature review;Frontiers in Cardiovascular Medicine;2024-06-07

3. Cardiovascular Management of Patients Undergoing Hematopoietic Stem Cell Transplantation: From Pretransplantation to Survivorship: A Scientific Statement From the American Heart Association;Circulation;2024-04-16

4. A review of chemotherapeutic drugs-induced arrhythmia and potential intervention with traditional Chinese medicines;Frontiers in Pharmacology;2024-03-20

5. A Review on Probable Causes of Cardiotoxicity Caused by Common Cancer Drugs and the Role of Traditional Chinese Medicine in Prevention and Treatment;Pharmacogenomics and Personalized Medicine;2023-12